TLR4 activation induces IL-1ss release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung by Eltom, Suffwan et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2014-08-02 
TLR4 activation induces IL-1ss release via an IPAF dependent but 
caspase 1/11/8 independent pathway in the lung 
Suffwan Eltom 
Imperial College London 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Genomics Commons, Immunopathology Commons, and the Respiratory Tract Diseases 
Commons 
Repository Citation 
Eltom S, Belvisi MG, Yew-Booth L, Dekkak B, Maher SA, Dubuis ED, Jones V, Fitzgerald KA, Birrell MA. 
(2014). TLR4 activation induces IL-1ss release via an IPAF dependent but caspase 1/11/8 independent 
pathway in the lung. Open Access Articles. https://doi.org/10.1186/s12931-014-0087-0. Retrieved from 
https://escholarship.umassmed.edu/oapubs/2420 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
RESEARCH Open Access
TLR4 activation induces IL-1β release via an IPAF
dependent but caspase 1/11/8 independent
pathway in the lung
Suffwan Eltom1, Maria G Belvisi1, Liang Yew-Booth1, Bilel Dekkak1, Sarah A Maher1, Eric D Dubuis1, Victoria Jones1,
Kate A Fitzgerald2 and Mark A Birrell1*
Abstract
Background: The IL-1 family of cytokines is known to play an important role in inflammation therefore understanding
the mechanism by which they are produced is paramount. Despite the recent plethora of publications dedicated
to the study of these cytokines, the mechanism by which they are produced in the airway following endotoxin,
Lipopolysaccharide (LPS), exposure is currently unclear. The aim was to determine the mechanism by which the
IL-1 cytokines are produced after LPS inhaled challenge.
Methods: Mice were challenged with aerosolised LPS, and lung tissue and bronchiolar lavage fluid (BALF)
collected. Targets were measured at the mRNA and protein level; caspase activity was determined using specific
assays.
Results: BALF IL-1b/IL-18, but not IL-1a, was dependent on Ice Protease-Activating Factor (IPAF), and to a lesser
extent Apoptosis-associated Speck-like protein containing a CARD (ASC). Interestingly, although we measured an
increase in mRNA expression for caspase 1 and 11, we could not detect an increase in lung enzyme activity or a
role for them in IL-1a/b production. Further investigations showed that whilst we could detect an increase in
caspase 8 activity at later points in the time course (during resolution of inflammation), it appeared to play no
role in the production of IL-1 cytokines in this model system.
Conclusions: TLR4 activation increases levels of BALF IL-1b/IL-18 via an IPAF dependent and caspase 1/11/8
independent pathway. Furthermore, it would appear that the presence of IL-1a in the BALF is independent of
these pathways. This novel data sheds light on innate signalling pathways in the lung that control the
production of these key inflammatory cytokines.
Keywords: TLR4, IPAF, ASC, IL-1 release
Background
The IL-1 family of cytokines are known to possess potent
pro-inflammatory properties [1,2] and controlling their
production and release is vital to maintaining a healthy
lung [3,4]. The family contains IL-1α and IL-1β, which
both activate the same receptor, IL-1R, [5] and IL-18
which activates the IL-18R [6,7]. All three cytokines are
transcribed into pro-forms and, whereas pro-IL-1α is
biologically active, pro-IL-1β and pro-IL-18 require
cleaving into their mature forms [8–11]. The production
of mature, active forms of IL-1β and IL-18 in many
scenarios is thought to involve a 2 step process: firstly
the transcription and translation of the pro-forms via a
stimulus such as a TLR agonist (i.e. LPS on TLR4) and
then a second stimulus that triggers the cleavage and
subsequent release of the mature form (i.e. ATP activat-
ing P2X7 receptors) [12–16]. Pro-IL-1β and pro-IL-18,
and not Pro-IL-1α, can be cleaved into mature forms by
caspase 1 [17]. Mature caspase 1 itself is activated/
cleaved from the inactive pro-form [17]. This could be
auto-processing [18] or via the actions of other kinases
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such as caspase 4 (or its murine homolog, caspase 11)
[19]. Caspase-11 does not process pro-IL-1β directly [20].
Depending on the stimulus and the conditions, caspase
1 can be recruited into a protein complex known as the
inflammasome which can include NALP3 (or NLRP3,
PYPAF1, CIAS1), AIM2, IPAF (or NLRC4, TMS1) and
ASC [17,21,22]. ASC is an adaptor molecule that is re-
quired in some instances to achieve partial or total activity
of the inflammasome [23]. The key proteins central to
IL-1β/IL-18 maturation depends on the stimulus and
conditions [24–26]. IL-1β and IL-18 have also been
shown to be released via caspase 1 independent mecha-
nisms [27–29]. Recently evidence has been published to
suggest caspase 8 can be involved in IL-1β maturation
[30]. Furthermore, in some circumstances it is thought
that the pro-forms are released and then cleaved into
the mature form by a range of enzymes including fungal
pathogens [31]; neutrophil proteinase-3 (PR3) [32,33];
mast cell chymase [34]; matrix metalloproteinases [35];
Cathepsin G [36] and a range of proteases including
granzyme A elastase [10,37,38].
Despite the recent plethora of publications dedicated
to the study of the IL-1 family of cytokines, the mechan-
ism by which they are produced in the airway after
endotoxin (LPS) exposure is currently unclear. Typically
experiments which investigate this signalling pathway
and the production of IL-1β family cytokines involve the
administration of lethal doses of LPS and the production
of systemic cytokines. However, it could be argued that
more moderate levels of LPS exposure, not resulting in
lethality, are more clinically relevant. Indeed, these more
moderate experimental protocols are known to result in
measurable levels of IL-1β in the mouse, rat and human
airway [39–43]. The aim of this study was to determine
the mechanism by which the IL-1 family members are
produced following after inhalation of the bacterial
mimetic LPS in a murine model.
Materials and methods
Mice
All in vivo protocols were approved by Imperial College
London ethical review process committee and we strictly
adhered to the Animals (Scientific Procedures) Act 1986
UK Home Office guidelines. Experiments were performed
under a Home office project licence (PPL 70/7212). Male
C57bl/6 mice (18-24 g) were originally obtained from
Harlan UK Limited (Bicester, UK) and bred in-house; food
and water supplied ad libitum. Genetically modified mice
(knockout, KOs) were back crossed at least 8 times and
bred alongside the wild type mice: TLR4 −/−, Myd 88 −/−,
P2X7 −/−, ASC −/−, NALP3 −/−, IPAF −/− IL-1β −/−,
IL-18 −/−, caspase 1 −/− and caspase 11 −/−. Recently
it has been established that due to the way they were
originally engineered, the caspase 1 KO mice are also
deficient in caspase 11 [44]. The KO mice were do-
nated from various laboratories: P2X7 from Professor
Jean Kanellopoulos from University Paris-Sud; Myd 88
−/−, TLR4 −/− and caspase 1 −/− from the Swiss Im-
munological Mouse Repository (SwImMR); IL-1b −/−
from Professor Yoichiro Iwakura from the University of
Tokyo, IL-18 −/− were from Jackson labs, USA; ASC −/−,
NALP3 −/−, and IPAF −/− from Professor Kate Fitzgerald
(via Professor Clare Bryant, Cambridge University),
University of Massachusetts Medical School and caspase
11 −/− from Professor Dixit, Genentech, USA.
Model system
Mice were challenged with aerosolised saline or sub-
maximal LPS (1 mg/ml, Escherichia coli serotype
0111:B4 from Sigma, UK [39]) in a perspex box for
30 minutes.
Time course study
Wild type mice were culled with an overdose of pento-
barbitone (Merial, France, 200 mg/kg, i.p.) at 2, 6, 24, 72
96 and 168 hours after the end of the challenge. Tail tips
were harvested and kept at -20°C for possible future
genotype confirmation. The trachea was cannulated
(Teflon precision dispensing tips, From Adhesive dis-
pensers Ltd, UK) and then lavaged with 0.3 ml RPMI
1640 (Invitrogen, UK) three times, and the lavage fluid
pooled. The chest was opened and the lung tissue
removed, cleaned and flash frozen in liquid nitrogen.
The lavage fluid was centrifuged at 900 g at 4°C for
10 minutes and the supernatant retained for cytokine
measurement. The cytokines were measured either by
Meso Scale Discovery (MSD, USA) technology or using
specific ELISAs from R&D systems, UK.
Gene expression levels were measured according to a
method we have previously described (McCluskie et al.,
2004). Briefly, RNA was extracted with TRI reagent
(Sigma, UK) and samples were reverse transcribed
using a master mix (Applied Biosystems, UK) in a
PerkinElmer 480 thermal cycler (PerkinElmer Life and
Analytical Sciences, USA). Transcriptional expression
of target mRNA transcripts in RNA samples were de-
tected by TaqMan real-time quantitative polymerase
chain reaction (PCR) with the ABI PRISM 7000 Sequence
Detection System (Applied Biosystems, UK). Fluorescent-
labelled TaqMan probes for target genes were purchased
from Applied Biosystems (UK). Reactions were internally
controlled with the 18S rRNA internal control (Applied
Biosystems, UK) and performed as multiplex reactions.
Validations were performed to ensure the reactions
were efficient. Caspase 1 and 8 activity in the lung tissue
was measured using specific commercially available as-
says. The caspase 1 assay and data is presented by Eltom
et al. [39]. For caspase 8 activity, the same lung tissue
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cytosolic fractions were assessed using a Caspase-Glo® 8
Assay (Promega, UK) according to the manufacturer’s
instructions.
Investigative studies
Wild type or GM mice were challenged with vehicle or
LPS (as above) and cytokine profile determined. In some
cases, target mRNA expression levels and caspase activity
was assessed.
Results
Time course for LPS driven response: IL-1 family and
associated machinery
Inhaled LPS caused a temporal increase in IL-1α, IL-1β,
IL-1R and IL-18R, but surprisingly not IL-18, mRNA
in mouse lung tissue (Figure 1). Indeed, it would
appear at the 24 hour time point there was a decrease
in expression of IL-18 mRNA. Measurement of BALF
levels of the same cytokines revealed that all three cy-
tokines are increased after LPS challenge compared to
vehicle challenged, time matched control (Figure 2).
Measurement of the machinery that is reported to be
associated with the release of the IL-1 family of cyto-
kines showed no change in IPAF mRNA, a transient
decrease in P2X7 receptor mRNA, and increases in ASC,
NALP3, caspase 1 and caspase 11 mRNA expression com-
pared to lungs from time-matched, control treated mice
(Figures 3 and 4).
The role of TLR4 and Myd88 in LPS responses
Compared to wild type, age matched controls; the
response to inhaled LPS was completely attenuated in
mice missing functional TLR4 and Myd88 as expected.
Levels of NALP3, caspase 11, IL-1α and IL-1β were
increased 6 hours after LPS challenge in wild type mice
and not in the KO mice indicating that the response
observed is dependent on TLR4 and Myd88 (Figure 5).
Parallel data was obtained when cytokine protein levels
were assessed in the BALF (data not shown).
Mechanism of cytokine release following LPS challenge
As discussed above, the P2X7 receptor has been linked
to the release of IL-1 family cytokines in configured cell
based assays. The LPS challenge caused a statistically
significant increase in IL-1 cytokines in the wild type
mice (Figure 6). The levels of IL-1α and IL-1β 6 hours
after challenge were not altered in the P2X7 KO mice;
the level of IL-18 did appear to be reduced, although this
did not reach statistical significance (Figure 6).
The inflammasome proteins have been associated with
processing and release of IL-1 family cytokines. Indeed
results from the time course showed that mRNA levels
of the NOD-like receptor NALP3 and adaptor molecule
ASC were increased in the lung tissue after LPS challenge
suggestive of a role in this process. However, data from a
study in which we compared the levels of IL-1 cytokines
in wild type mice to those measured in mouse lines miss-
ing key inflammasome proteins, showed that IL-1β and
IL-18 levels were decreased in the IPAF and ASC KO mice
but interestingly not the NALP3 KO mice (Figure 7). The
levels of IL-1α were not altered in any of the GM lines
tested (Figure 7).
As discussed above, dogma suggests that IPAF and
ASC are involved in the maturation of IL-1 cytokines.
To examine this we measured the levels of IL-1β in the
lung tissue from the study with the inflammasome KO
Figure 1 Expression of IL-1 family (mRNA levels). Male C57bl/6 mice were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for
30 minutes. Lung tissue was collected at different time points after the exposure and mRNA expression of IL-1α (Α), IL-1β (Β), IL-18 (C), IL-1R
(D) and IL-18R (E) measured by real time PCR. Data are represented as mean ± S.E.M. for n = 6 animals in each group. Statistical significance
was determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and vehicle exposed
wild-type groups.
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mice. As expected LPS challenge increased the mRNA
level of IL-1β (4.4 to 64.4 2^-dct × 106), and this was not
altered in the IPAF (69.5 2^-dct × 106) KO mice.
Caspase 1 and 11 have been reported to be central to
the maturation of IL-1 cytokines and have been linked
to IPAF, thus we wanted to explore the role of these
enzymes in our system. In these studies, LPS challenge
caused a significant increase in IL-1 cytokines in the
wild type mice. In the caspase 1/11 and caspase 11 KO
mice the levels of BALF IL-1α and IL-1β were not
altered (Figure 8). In both GM lines the levels of IL-18
were reduced but this failed to reach statistical significance
(Figure 8). There were no statistically significant differ-
ences in the cytokine levels of the vehicle challenged
GM mice compared to wild type comparators (data not
shown).
As it appeared that neither caspase 1 nor 11 were
necessary for LPS induced IL-1 cytokines in the BALF,
we studied the role of another caspase recently linked to
the maturation and release of these cytokines, caspase 8
[30,45,46]. Caspase 8 KO mice are embryonically lethal
[47] and there are currently no selective caspase 8 inhib-
itors suitable for in vivo studies. Thus we decided to
measure caspase 8 activity to investigate its role in LPS
induced BALF IL-1 cytokine levels. In the lung samples
from the time course study we could detect an increase
in caspase 8 activity (Figure 9). The temporal increase in
activity did not appear to correlate with the presence of
IL-1 cytokines in the BAL but appeared to be associated
with the resolution of the cellular inflammation suggest-
ing the increase is related to apoptosis of the white cells.
Further evidence for the lack of a role for caspase 8 in
the production of IL-1 cytokines is suggested by the fact
that caspase 8 activity was reduced in the IPAF KO mice
(Figure 9B).
IL-1β and IL-18 have been suggested to be linked to
the release of IL-1α [48,49]. To explore this in our
model system we used IL-1β and IL-18 KO mice, with
caspase 1/11 KOs as negative controls. As expected the
LPS challenge caused a significant increase in BALF
IL-1α which was, however, not altered in the KO mice
(Figure 9C).
Discussion
The IL-1 family of cytokines are known to play an im-
portant inflammatory role in many biological processes
Figure 2 Expression of IL-1 family (protein levels). Male C57bl/6 mice were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for
30 minutes. BALF was collected at different time points after the exposure and IL-1α (A), IL-1β (B) and IL-18 (C) measured by ELISA. Data are
represented as mean ± S.E.M. for n = 6 animals in each group. Statistical significance was determined using Mann–Whitney U test. # = P < 0.05,
denoting a significant difference between the LPS exposed and vehicle exposed wild-type groups.
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Figure 4 Expression of P2X7, caspase 1 and caspase 11 mRNA levels. Male C57bl/6 mice were exposed to vehicle (aerosolised saline) or LPS
(1 mg/ml) for 30 minutes. Lung tissue and BALF was collected at different time after the exposure. Lung tissue levels of P2X7 (A), caspase 1 (B)
and caspase 11 (C) mRNA expression were detected by real time PCR. Data are represented as mean ± S.E.M. for n = 6 animals in each group.
Statistical significance was determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and
vehicle exposed wild-type groups.
Figure 3 Expression of ASC, NALP3 and IPAF mRNA levels. Male C57bl/6 mice were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for
30 minutes. Lung tissue was collected at different time points after the exposure. Lung tissue levels of ASC (A), NALP3 (B) and IPAF (C)mRNA expression
were detected by real time RT-PCR. Data are represented as mean ± S.E.M. for n = 6 animals in each group. Statistical significance was determined using
Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and vehicle exposed wild-type groups.
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in the lung. Currently the mechanisms involved are
unknown and understanding how these cytokines are
produced is of paramount importance. Recently, re-
search has focussed on the proposed 2 step process by
which these cytokines are thought to be produced. In
general the studies involve using configured cells
grown from monocytes (i.e. blood) or harvested from
body compartments (i.e. thioglycollate dosed periton-
eal cavity, bone marrow) and when in vivo systems
have been used often the end point used is death. How-
ever, it is well known that in the airway non-lethal,
endotoxin challenge alone can cause the release of IL-1
cytokines in a range of species, including man [39–43].
Furthermore, LPS challenge models in man are becoming
an increasingly popular investigative tool for new medica-
tions targeting COPD. Therefore, the aim of this study
was to determine the mechanism by which the IL-1 family
members are produced after activation of TLR4 by inhaled
bacterial mimetic LPS.
In time course studies inhaled LPS triggered a rapid
increase in IL-1α, IL-1β and IL-18 protein in the BALF
but only increased IL-1α and IL-1β mRNA levels in the
lung tissue. This would suggest that unlike IL-1α and β,
IL-18 is not induced transcriptionally in this model sys-
tem. Indeed, there is a strong signal for IL-18 mRNA in
unchallenged mouse lungs and at the 24 hour time point
following LPS challenge there appeared to be a decrease
in IL-18 mRNA. This could because the mRNA is being
used to replenish the normal stored levels of pro-IL-18,
something that has been suggested in other lung inflam-
mation models [50]. When we studied the expression of
the machinery reported to be involved in the release of
IL-1 cytokines, we found that ASC, NALP3, caspase 1
and caspase 11 were increased at the mRNA level,
whereas P2X7 receptor expression was transiently re-
duced and IPAF levels were below reliable detection
limits. Whilst, as far as we are aware, these markers have
not been comprehensively measured in the mouse lung
after LPS challenge, there are reports of similar increases
in cultured cell systems [19,51]. The decrease in P2X7
receptor mRNA expression is interesting. Previously a
group has described an increase in P2X7 receptor protein
expression in their mouse endotoxin challenge model, the
difference could be down to the different experimental
designs (i.e. dosing of LPS, timing of sampling) and
measuring mRNA versus protein [52]. In addition, whilst
Figure 5 Role of TLR4 and Myd88 in the expression of IL-1 family and associated markers. Wild type, age matched control mice and GM
mice (mice missing functional TLR4 or Myd88) were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. Lung tissue was
collected 6 hours after the exposure. Lung tissue levels of mRNA expression were detected by RT-PCR NALP3 (A), Caspase 11 (B), IL-1α (C) and
IL-1β (D). Data are represented as mean ± S.E.M. for n = 4 animals in each group. Statistical significance was determined using Mann–Whitney U test.
# = P < 0.05, denoting a significant difference between the LPS exposed and vehicle exposed wild-type groups; * = P < 0.05, denoting a significant
difference between the LPS exposed GM and wild-type mice (one-way ANOVA).
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we did observe a transient reduction in P2X7 receptor
mRNA expression, this may not be indicative of changes
in protein levels and other factors like levels of ligands
and signalling/coupling status are more likely to be
biologically important. On balance the expression data
suggests that the endotoxin challenge is priming the
machinery known to be associated with the release of
IL-1 cytokine in the airway. One caveat, however, that
could be argued is that these mRNA expression
changes are due to an altered cellular burden observed
after LPS challenge [39].
To determine if the increased expression was
dependent on TLR4 and a key protein in the signalling
cascade, Myd88, we repeated the experiment in GM mice
missing functional proteins. The data clearly showed that
TLR4 and Myd88 are required for the LPS induced in-
crease in NALP3, caspase 11, IL-1α and IL-1β expression
and whilst we cannot exclude the possibility that LPS
enters the cell and directly interacts with proteins (similar
to NODs), it seems likely that TLR4 and Myd88 play a
crucial role in the response.
To begin to explore the mechanism by which IL-1
cytokines are released into the BAL, we explored the
role of the P2X7 receptor. Although in these studies we
challenged with LPS alone it is possible that this recep-
tor is being stimulated by endogenously produced
stimuli (i.e. ATP) and that this triggers the second
signal known to cause the maturation of IL-1 cytokines.
Indeed Monção-Ribeiro et al. [52] found that mice miss-
ing functional P2X7 had reduced levels of IL-1β. In these
studies P2X7 KO mice had similar levels of IL-1α and IL-1
compared to age matched, wild type controls suggesting
that endogenous P2X7 receptor activators are not pro-
duced in our model system. The reason for the discrep-
ancy between data sets is not known but our data is in
line with a previous finding that LPS challenge did not
increase caspase 1 activity (a downstream marker of
P2X7 receptor activation) [39]. Furthermore, we have
detected an increase in BALF ATP levels in a smoke
driven model [53], but no similar increase after LPS
challenge (data not shown).
As discussed the IL-1 family of cytokines have been
closely linked to inflammasome proteins; there are a
range of publications linking the maturation and release
of IL-1 cytokines to NALP3, ASC and IPAF. When we
investigated their involvement in this system we found
that although NALP3 expression was increased by LPS
challenge, it was not necessary for the release of the IL-1
Figure 6 Role of P2X7 receptor in the expression of IL-1 family. Wild type, age matched control mice and GM mice (mice missing functional
P2X7) were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. BALF was collected 6 hours after the exposure and IL-1α (A),
IL-1β (B) and IL-18 (C) measured by ELISA. Data are represented as mean ± S.E.M. for n = 8 animals in each group. Statistical significance was
determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and vehicle exposed
wild-type groups.
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Figure 7 Role of the inflammasome in the expression of IL-1 family. Wild type, age matched control mice and GM mice (mice missing functional
ASC, NALP3 and IPAF) were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. BALF was collected 6 hours after the exposure
and IL-1α (A), IL-1β (B) and IL-18 (C) measured by ELISA. Data are represented as mean ± S.E.M. for n = 8 animals in each group. Statistical significance
was determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and vehicle exposed wild-type
groups; * = P < 0.05, denoting a significant difference between the LPS exposed GM and wild-type mice (one-way ANOVA).
Figure 8 Role of caspase 1 and 11 the expression of IL-1 family. Wild type, age matched control mice and GM mice (mice missing
functional caspase 1/11 and caspase 11) were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. BALF was collected
6 hours after the exposure and IL-1α (A or D), IL-1β (B or E) and IL-18 (C or F) measured by ELISA. Data are represented as mean ± S.E.M. for
n = 8 animals in each group. Statistical significance was determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference
between the LPS exposed and vehicle exposed wild-type groups.
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cytokines. IPAF, and to a lesser extent ASC, did appear
to be required for IL-1β and IL-18, but interestingly
not IL-1α. There are a number of reports that have, in
general, have linked IPAF and ASC with mature IL-1
cytokine production in a caspase-dependent manner
[54–57]. However, although we measured an increase
in caspase 1, and its reported activator [44] caspase 11,
surprisingly the caspase 1/11 or caspase 11 KO mice
did not have reduced IL-1 cytokines. Whilst caspase 11
is not thought to process pro-IL-1β directly, it has
been reported to cleave pro-caspase 1 into the mature
active form and it has also been linked to the release of
IL-1α [19,20]. This data led us to the conclusion that
the release of IL-1 cytokines was either dependent on
another caspase or was independent of caspase enzyme
activity. Recently it has been reported that caspase 8
can cleave pro-IL-1β [30]. We could not adopt our
normal strategy and employ GM mice because block-
ing caspase 8 activity results in embryonic lethality
[47] and as yet there are no selective pharmacological
inhibitors with the correct profile for in vivo use. Thus
we utilised the specific activity assay to look for an
increase in caspase 8 activity and to determine if it was
decreased in the IPAF KO mice (on the assumption
that IPAF would be upstream of caspase 8). Whilst we
did detect an increase in caspase 8 activity in the lung
tissue, it appeared to temporally correlate with the
resolution of the inflammation (i.e. associated with
apoptosis) and any increase observed at the time points
we measured IL-1 cytokines was not altered in the
IPAF KOs. Together this data would suggest that the
IL-1β and IL-18 measured in the BALF was dependent
on IPAF but independent of caspase 1, 8 and 11 and
would imply that other mechanisms are involved in the
maturation of these cytokines as discussed previously.
One candidate would be the matrix metalloproteinases
[35] and we have previously reported that there is an
increase in MMPs in the lung after LPS challenge [58].
However, data from a study in which we used a pan
MMP inhibitor showed no change in IL-1β levels
which would question this hypothesis [59].
Whilst we were able to determine that TLR4 and
Myd88 were essential for LPS- induced IL-1α production
in the BALF, we were unable to delineate further down
Figure 9 Role of caspase 8 the expression of IL-1 family. Male C57bl/6 mice were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for
30 minutes. Lung tissue was collected at different time after the exposure and caspase 8 activity measured (A). Data are represented as mean ± S.
E.M. for n = 6 animals in each group. Wild type, age matched control mice and GM mice (mice missing functional ASC and IPAF) were exposed
to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. Lung tissue was collected at different time after the exposure and caspase 8
activity measured (B). Data are represented as mean ± S.E.M. for n = 6 animals in each group. Wild type, age matched control mice and GM mice
(mice missing functional IL-1β, IL-18 and caspase 1/11) were exposed to vehicle (aerosolised saline) or LPS (1 mg/ml) for 30 minutes. BALF was
collected 6 hours after the exposure and IL-1α (C) measured by ELISA. Data are represented as mean ± S.E.M. for n = 8 animals in each group.
Statistical significance was determined using Mann–Whitney U test. # = P < 0.05, denoting a significant difference between the LPS exposed and
vehicle exposed wild-type groups.
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the pathway. Reports have suggested that other IL-1 fam-
ily members can act as chaperones for IL-1α but the data
with IL-1β and IL-18 KO mice clearly showed that in this
system this was not the case. Others have suggested that
members of the calpain family of proteases are involved
[60,61] whereas recently Lukens et al. [62] have reported
that RIP1 driven auto-inflammation targets IL-1α inde-
pendently of the inflammasome. Further, investigation
is required to determine the mechanism by which LPS
induces an increase in BALF IL-1α after LPS.
In conclusion, the data suggests that activation of
TLR4 increases levels of BALF IL-1β and IL-18 via an
IPAF dependent and caspase 1/11/8 independent path-
way. We have attempted to capture this in a schematic
(Figure 10). Furthermore, it would appear that IL-1α is
produced via a different mechanism. These are import-
ant, novel findings that further our understanding of
this prominent family of inflammatory cytokines in the
lung and their role in the innate immune system.
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Figure 10 Schematic representative of the in vivo data. Our data suggests that in the mouse inhaled LPS activates TLR4 in the airway to
trigger MyD88 dependent increase mRNA production of pro-IL-1α, pro-IL-1β, pro-Caspase 1, pro-caspase 11, ASC and NALP3, but not pro-IL-18 or IPAF.
These increases in mRNA levels are likely to be associated with an increase in the corresponding protein levels. The pro-Caspase 1, pro-caspase 11, ASC
and NALP3 are then primed ready for a second stimulus (i.e. via ATP-P2X7) and subsequent processing of pro-IL-1β and pro-IL-18. The LPS stimulus
causes caspase 1/caspase 11 independent release of IL-1α, IL-1β and IL-18 into the airway lumen (either in the pro or mature form), of which the latter
two appear to require IPAF. Pro-forms of the cytokines could be cleaved to the mature forms outside the cell.
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